Here are the top updates from Monday: A study published in medical journal The Lancet said that it was not appropriate to give booster d...
Here are the top updates from Monday:
- A study published in medical journal The Lancet said that it was not appropriate to give booster doses of Covid-19 vaccine to the general population at this stage of the pandemic as the efficacy of the shots against severe cases, even for the Delta variant, was high, reported PTI. The authors said the efficacy of all types of vaccines is greater against cases of severe disease than against mild ones.
- India registered 27,254 new coronavirus cases, pushing the country’s overall tally of infections since the outbreak of the pandemic in January last year to 3,32,64,175. The new cases were 4.6% lower than Sunday’s count of 28,591. The country’s toll rose to 4,42,874 as it recorded 219 deaths in the last day.
- India crossed the 75 crore mark in administering Covid-19 vaccine doses to beneficiaries since the immunisation drive began in January, according to CoWin portal data. As many as 18,04,49,440 beneficiaries have received both the shots.
- Dr NK Arora, chairperson of the Covid-19 working group, said that Bharat Biotech’s Covaxin will likely receive the World Health Organization’s Emergency Use Listing within a week, reported ANI.
- The Supreme Court asked the Centre to reconsider its decision to exclude those who were infected with Covid-19 disease and died...
